About Us

Guiding Cells to Improve Life

Fate Therapeutics is a clinical‑stage biopharmaceutical company engaged in the development of programmed cellular immunotherapeutics for the treatment of severe, life‑threatening diseases.  We have built a novel platform to program the function and fate of immune cells ex vivo using pharmacologic modulators, such as small molecules, which promote rapid and supra-physiologic activation and inhibition of a cell’s transcriptional program.  We are focused on developing our programmed cellular candidates as therapeutic entities for the treatment of cancer, rare genetic diseases and immune disorders.  To accomplish our development objectives, we are applying our cell programming technology to develop three franchises of cellular immunotherapeutics: